PortfoliosLab logo
Tools
Performance Analysis
Risk Analysis
Optimization
Factor Model
See All Tools
Portfolio Analysis
Portfolios
Lazy PortfoliosUser Portfolios
Discussions
United Laboratories International Holdings Ltd (39...
Performance
Risk-Adjusted Performance
Dividends
Drawdowns
Volatility
Financials

Company Info

ISINKYG8813K1085
SectorHealthcare
IndustryDrug Manufacturers - Specialty & Generic

Highlights

Market CapHK$15.59B
PE Ratio5.26
Total Revenue (TTM)HK$6.91B
Gross Profit (TTM)HK$3.21B
Year RangeHK$5.59 - HK$10.78
Target PriceHK$12.74

Share Price Chart


Loading data...

Compare to other instruments

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


United Laboratories International Holdings Ltd

Performance

Performance Chart

The chart shows the growth of an initial investment of HK$10,000 in United Laboratories International Holdings Ltd, comparing it to the performance of the S&P 500 index or another benchmark. All prices have been adjusted for splits and dividends.


150.00%200.00%250.00%300.00%2024FebruaryMarchAprilMayJune
236.39%
250.42%
3933.HK (United Laboratories International Holdings Ltd)
Benchmark (^GSPC)

S&P 500

Returns By Period

United Laboratories International Holdings Ltd had a return of 22.40% year-to-date (YTD) and 28.68% in the last 12 months. Over the past 10 years, United Laboratories International Holdings Ltd had an annualized return of 6.88%, while the S&P 500 had an annualized return of 10.77%, indicating that United Laboratories International Holdings Ltd did not perform as well as the benchmark.


PeriodReturnBenchmark
Year-To-Date22.40%12.69%
1 month-18.90%2.92%
6 months23.81%15.76%
1 year28.68%23.89%
5 years (annualized)19.78%13.23%
10 years (annualized)6.88%10.77%

Monthly Returns

The table below presents the monthly returns of 3933.HK, with color gradation from worst to best to easily spot seasonal factors. Returns are adjusted for dividends.


JanFebMarAprMayJunJulAugSepOctNovDecTotal
2024-3.71%25.93%5.41%3.01%-2.49%22.40%
20235.92%-9.44%16.17%16.12%8.83%-5.22%-2.44%12.52%15.14%0.76%0.13%-12.37%49.12%
20221.38%-2.26%-4.63%-6.07%-3.10%24.00%-9.13%-7.97%-12.84%0.61%23.71%20.39%16.49%
2021-2.00%4.64%1.77%10.80%13.99%-12.14%-13.07%-3.67%-0.49%-4.83%-9.53%-2.24%-18.77%
2020-9.68%1.36%20.19%7.84%2.37%-2.90%8.96%26.18%-12.40%-16.79%-12.50%-5.34%-2.09%
20196.97%6.97%-2.52%-1.08%-3.49%-3.77%3.10%4.17%-8.45%9.47%6.43%18.33%38.92%
20187.87%18.25%0.37%4.92%6.92%-9.79%-8.45%-5.08%-2.25%-21.47%-3.12%-21.21%-34.03%
2017-8.14%3.09%1.40%-3.75%6.35%-0.77%-4.86%24.29%-4.43%16.67%-7.22%0.79%20.27%
2016-31.93%-3.08%10.25%3.85%-1.85%-4.09%-0.65%15.51%28.57%-4.67%-2.10%25.71%23.08%
2015-15.45%-7.31%2.26%44.35%13.93%-6.03%-16.58%-17.09%1.55%5.08%3.86%-0.23%-5.30%
201443.41%7.85%-3.74%7.99%-4.00%10.42%-2.64%15.50%-1.85%1.71%-11.93%-13.55%45.66%
2013-4.05%5.63%-8.27%-15.40%1.03%-5.78%7.94%-7.36%1.08%16.78%-2.75%-2.20%-15.95%

Risk-Adjusted Performance

Risk-Adjusted Performance Rank

The current rank of 3933.HK is 68, suggesting that the investment has average results relative to other stocks in terms of risk-adjusted performance. This ranking is determined by the cumulative values of the indicators listed below.


The Risk-Adjusted Performance Rank of 3933.HK is 6868
3933.HK (United Laboratories International Holdings Ltd)
The Sharpe Ratio Rank of 3933.HK is 6868Sharpe Ratio Rank
The Sortino Ratio Rank of 3933.HK is 6666Sortino Ratio Rank
The Omega Ratio Rank of 3933.HK is 6464Omega Ratio Rank
The Calmar Ratio Rank of 3933.HK is 7070Calmar Ratio Rank
The Martin Ratio Rank of 3933.HK is 7070Martin Ratio Rank
The risk-adjusted ranks indicate the investment's position relative to the market. A rank closer to 100 signifies top-performing investments, while a rank closer to 0 might suggest underperformance, based on the selected ratio. The values are calculated based on the past 12 months of returns.

Risk-Adjusted Performance Indicators

The charts below present risk-adjusted performance metrics for United Laboratories International Holdings Ltd (3933.HK) and compare them to a chosen benchmark (^GSPC). These indicators evaluate an investment's returns against its associated risks.


3933.HK
Sharpe ratio
The chart of Sharpe ratio for 3933.HK, currently valued at 0.59, compared to the broader market-2.00-1.000.001.002.003.000.59
Sortino ratio
The chart of Sortino ratio for 3933.HK, currently valued at 1.17, compared to the broader market-4.00-2.000.002.004.006.001.17
Omega ratio
The chart of Omega ratio for 3933.HK, currently valued at 1.15, compared to the broader market0.501.001.502.001.15
Calmar ratio
The chart of Calmar ratio for 3933.HK, currently valued at 0.52, compared to the broader market0.002.004.006.000.52
Martin ratio
The chart of Martin ratio for 3933.HK, currently valued at 2.30, compared to the broader market0.0010.0020.002.30
^GSPC
Sharpe ratio
The chart of Sharpe ratio for ^GSPC, currently valued at 2.21, compared to the broader market-2.00-1.000.001.002.003.002.21
Sortino ratio
The chart of Sortino ratio for ^GSPC, currently valued at 3.13, compared to the broader market-4.00-2.000.002.004.006.003.13
Omega ratio
The chart of Omega ratio for ^GSPC, currently valued at 1.39, compared to the broader market0.501.001.502.001.39
Calmar ratio
The chart of Calmar ratio for ^GSPC, currently valued at 1.77, compared to the broader market0.002.004.006.001.77
Martin ratio
The chart of Martin ratio for ^GSPC, currently valued at 8.30, compared to the broader market0.0010.0020.008.30

Sharpe Ratio

The current United Laboratories International Holdings Ltd Sharpe ratio is 0.59. This value is calculated based on the past 1 year of trading data and takes into account price changes and dividends.

Use the chart below to compare the Sharpe ratio of United Laboratories International Holdings Ltd with the selected benchmark, providing insights into the investment's historical performance in terms of risk-adjusted returns. Go to the Sharpe ratio tool for more fine-grained control over the calculation options.


Rolling 12-month Sharpe Ratio0.501.001.502.002.503.002024FebruaryMarchAprilMayJune
0.59
2.18
3933.HK (United Laboratories International Holdings Ltd)
Benchmark (^GSPC)

Dividends

Dividend History

United Laboratories International Holdings Ltd granted a 3.31% dividend yield in the last twelve months. The annual payout for that period amounted to HK$0.28 per share.


PeriodTTM202320222021202020192018
DividendHK$0.28HK$0.28HK$0.15HK$0.14HK$0.08HK$0.07HK$0.06

Dividend yield

3.31%4.05%3.06%3.32%1.39%1.20%1.47%

Monthly Dividends

The table displays the monthly dividend distributions for United Laboratories International Holdings Ltd. The dividends shown in the table have been adjusted to account for any splits that may have occurred.


JanFebMarAprMayJunJulAugSepOctNovDecTotal
2024HK$0.00HK$0.00HK$0.00HK$0.00HK$0.00HK$0.00HK$0.00
2023HK$0.00HK$0.00HK$0.00HK$0.00HK$0.00HK$0.00HK$0.15HK$0.00HK$0.13HK$0.00HK$0.00HK$0.00HK$0.28
2022HK$0.00HK$0.00HK$0.00HK$0.00HK$0.00HK$0.00HK$0.09HK$0.00HK$0.06HK$0.00HK$0.00HK$0.00HK$0.15
2021HK$0.00HK$0.00HK$0.00HK$0.00HK$0.00HK$0.00HK$0.10HK$0.00HK$0.05HK$0.00HK$0.00HK$0.00HK$0.14
2020HK$0.00HK$0.00HK$0.00HK$0.00HK$0.00HK$0.00HK$0.08HK$0.00HK$0.00HK$0.00HK$0.00HK$0.00HK$0.08
2019HK$0.00HK$0.00HK$0.00HK$0.00HK$0.00HK$0.07HK$0.00HK$0.00HK$0.00HK$0.00HK$0.00HK$0.00HK$0.07
2018HK$0.06HK$0.00HK$0.00HK$0.00HK$0.00HK$0.00HK$0.00HK$0.06

Dividend Yield & Payout


Dividend Yield
5.0%10.0%15.0%3.3%
United Laboratories International Holdings Ltd has a dividend yield of 3.31%, which is quite average when compared to the overall market.
Payout Ratio
20.0%40.0%60.0%80.0%100.0%120.0%17.7%
United Laboratories International Holdings Ltd has a payout ratio of 17.73%, which is below the market average. This means United Laboratories International Holdings Ltd returns a smaller proportion of its earnings to shareholders as dividends, suggesting it retains a higher portion for reinvestment, growth, or debt payment.

Drawdowns

Drawdowns Chart

The Drawdowns chart displays portfolio losses from any high point along the way.


-50.00%-40.00%-30.00%-20.00%-10.00%0.00%2024FebruaryMarchAprilMayJune
-35.75%
0
3933.HK (United Laboratories International Holdings Ltd)
Benchmark (^GSPC)

Worst Drawdowns

The table below displays the maximum drawdowns of the United Laboratories International Holdings Ltd. A maximum drawdown is a measure of risk, indicating the largest reduction in portfolio value due to a series of losing trades.

The maximum drawdown for the United Laboratories International Holdings Ltd was 83.09%, occurring on Jul 10, 2013. The portfolio has not yet recovered.

The current United Laboratories International Holdings Ltd drawdown is 35.75%.


Depth

Start

To Bottom

Bottom

To Recover

End

Total

-83.09%Sep 14, 2010695Jul 10, 2013
-75.08%Oct 16, 2007271Nov 21, 2008331Mar 24, 2010602
-26.39%Jul 10, 200729Aug 17, 200714Sep 6, 200743
-20.99%May 19, 20104May 25, 201015Jun 15, 201019
-14.01%Sep 14, 200713Oct 4, 20074Oct 10, 200717

Volatility

Volatility Chart

The current United Laboratories International Holdings Ltd volatility is 8.46%, representing the average percentage change in the investments's value, either up or down over the past month. The chart below shows the rolling one-month volatility.


5.00%10.00%15.00%2024FebruaryMarchAprilMayJune
8.46%
2.39%
3933.HK (United Laboratories International Holdings Ltd)
Benchmark (^GSPC)

Financials

Financial Performance

The chart below illustrates the trends in the financial health of United Laboratories International Holdings Ltd over time, highlighting three key metrics: Total Revenue, Earnings Before Interest and Taxes (EBIT), and Net Income.

Annual
Quarterly

0.0

Income Statement


Income Statement
Balance Sheet
Cash Flow
Annual
Quarterly

TTM
Revenue

Total Revenue

Cost Of Revenue

Gross Profit

Operating Expenses

Selling, General & Admin Expenses

R&D Expenses

Depreciation And Amortization

Total Operating Expenses

Income

Income Before Tax

Operating Income

EBITDA

EBIT

Earnings From Continuing Operations

Net Income

Income Tax Expense

Other Non-Operating Income (Expenses)

Extraordinary Items

Discontinued Operations

Effect Of Accounting Charges

Non Recurring

Minority Interest

Other Items

Interest Income

Interest Expense

Net Interest Income

Values in undefined except per share items